ROCKET PHARMACEUTICALS, INC. (RCKT)
About ROCKET PHARMACEUTICALS, INC.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $0
- Net income
- -$223.1M
- Total assets
- $330.4M
- Market cap
- $300.3M
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $231.7M
- Operating income
- -$231.7M
- Income tax
- $0
- Net income
- -$223.1M
- EPS (basic)
- $-2.01
- EPS (diluted)
- $-2.01
Balance sheet
- Total assets
- $330.4M
- Current assets
- $192.7M
- Total liabilities
- $53.2M
- Current liabilities
- $30.2M
- Shareholders’ equity
- $277.2M
Cash flow
- Operating cash flow
- -$190.0M
- Investing cash flow
- $103.8M
- Financing cash flow
- $148.0K
- Net cash flow
- -$86.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $300.3M
- EPS (diluted)
- $-2.01
- Shares outstanding
- 94.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 18, 2015
Rocket Pharmaceuticals, Inc. (RCKT) Stock Price
- Reported a net loss of $223.1M in FY2025.
- Trading 40% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ROCKET PHARMACEUTICALS, INC..
Write a review
News about ROCKET PHARMACEUTICALS, INC.
News & sentiment via Polygon.io
Rocket Pharmaceuticals, Inc.: frequently asked questions
Is Rocket Pharmaceuticals, Inc. an American company?
Rocket Pharmaceuticals, Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Rocket Pharmaceuticals, Inc. headquartered?
Rocket Pharmaceuticals, Inc. is headquartered in New York, New York, United States.
Is Rocket Pharmaceuticals, Inc. publicly traded?
Yes — Rocket Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol RCKT on the NASDAQ.
What does Rocket Pharmaceuticals, Inc. do?
Rocket Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
